Fitton, Catherine ASteiner, Markus F CAucott, LornaPell, J. P.Mackay, Daniel FFleming, MichaelMcLay, James S2017-07-252017-07-252017-11Fitton, C A, Steiner, M F C, Aucott, L, Pell, J P, Mackay, D F, Fleming, M & McLay, J S 2017, 'In-utero exposure to antihypertensive medication and neonatal and child health outcomes : a systematic review', Journal of Hypertension, vol. 35, no. 11, pp. 2123-2137. https://doi.org/10.1097/HJH.00000000000014560263-6352ORCID: /0000-0001-6277-7972/work/84132166http://hdl.handle.net/2164/8990ACKNOWLEDGEMENTS We acknowledge the support from the Farr Institute at Scotland. The Farr Institute at Scotland is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), the Wellcome Trust, (MRC Grant No: MR/K007017/1).15259753engSDG 3 - Good Health and Well-beingadverse drug eventantihypertensive agentschild healthdrug exposure in pregnancyfemalehypertensionin-utero exposurepharmacovigilancepreeclampsiapregnancy-induced hypertensionR MedicineArthritis Research UK (ARUK)British Heart FoundationCancer Research UKEconomic and Social Research Council (ESRC)Engineering and Physical Sciences Research Council (EPSRC)Medical Research Council (MRC)MR/K007017/1National Institute for Health Research (NIHR)Chief Scientist Office (CSO)Wellcome TrustRIn-utero exposure to antihypertensive medication and neonatal and child health outcomes : a systematic reviewJournal article10.1097/HJH.00000000000014563511